Table 1.
Infections of positive diagnoses detected during the first wave.
| Species of bacteria (abbreviation) | Infected patients: (N=83) | Positive diagnoses (N=284) |
|---|---|---|
| Staphylococcus epidermidis (S.ep) | 21 (25,3%) | 39 (13,7%) |
| Escherichia coli (E.co) | 21 (25,3%) | 28 (9,9%) |
| Enterococcus faecalis (E.fa) | 20 (24,1%) | 39 (13,7%) |
| Staphylococcus aureus (S.au) | 11 (13,2%) | 53 (18,7%) |
| Enterococcus faecium (E.fa1) | 11 (13,2%) | 18 (6,3%) |
| Staphylococcus hominis (S.ho) | 10 (12,0%) | 18 (6,3%) |
| Staphylococcus haemolyticus (S.ha) | 9 (10,8%) | 11 (3,9%) |
| Klebsiella pneumoniae (K.pn) | 8 (9,6%) | 18 (6,3%) |
| Proteus mirabilis (P.mi) | 5 (6,0%) | 9 (3,2%) |
| Pseudomonas aeruginosa (P.ae) | 4 (4,8%) | 10 (3,5%) |
| Bacillus clausii (B.cl) | 4 (4,8%) | 5 (1,8%) |
| Enterobacter cloacae (E.cl) | 2 (2,4%) | 2 (0,7%) |
| Morganella morganii (M.mo) | 2 (2,4%) | 2 (0,7%) |
| Providencia stuartii (P.st) | 2 (2,4%) | 2 (0,7%) |
| Stafilococco aureo Meticillino Resistente (S.au.Res) | 1 (1,2%) | 9 (3,2%) |
| Serratia marcescens (S.ma) | 1 (1,2%) | 3 (1,1%) |
| Corynebacterium urealyticum (C.ur) | 1 (1,2%) | 2 (0,7%) |
| Enterobacter aerogenes (E.ae) | 1 (1,2%) | 2 (0,7%) |
| Staphylococcus capitis (S.ca) | 1 (1,2%) | 2 (0,7%) |
| Staphylococcus cohnii (S.co) | 1 (1,2%) | 2 (0,7%) |
| Aerococcus viridans (A.vi) | 1 (1,2%) | 1 (0,3%) |
| cocco-bacilli Gram positivi (Cc.pos) | 1 (1,2%) | 1 (0,3%) |
| Corynebacterium amycolatum (C.am) | 1 (1,2%) | 1 (0,3%) |
| Corynebacterium striatum (C.st) | 1 (1,2%) | 1 (0,3%) |
| K. pneumoniae resistente ai carbapenemi (K.pn.res) | 1 (1,2%) | 1 (0,3%) |
| Stafilococco aureo Meticillino Sensibile (S.au.sen) | 1 (1,2%) | 1 (0,3%) |
| Staphylococcus pettenkoferi (S.pe) | 1 (1,2%) | 1 (0,3%) |
| Stenotrophomonas maltophilia (S.ma1) | 1 (1,2%) | 1 (0,3%) |
| Streptococcus parasanguis (S.pa) | 1 (1,2%) | 1 (0,3%) |
| Str. beta emol. Gr.F (Str.be) | 1 (1,2%) | 1 (0,3%) |
Legend: For each species of bacteria: the prevalence (percentage of infection) was defined as the proportion of infected patients over the total number of patients (n=83); the percentage of positive diagnoses was calculated by the proportion of positive diagnoses over the total number of laboratory investigations (n=284).